Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

After more than a decade of dog treats and deliveries, a UPS driver in Georgia shared an emotional moment with a couple of ...

MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...

A panelist discusses recent advancements in bispecific antibody therapies for relapsed/refractory multiple myeloma, ...

Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

Early Phase I results for JNJ-79635322 demonstrated an 86.1% overall response rate in heavily pretreated multiple myeloma patients, including a 100% response in those naïve to B-cell maturation ...

These activities are further supported by the in-vivo data demonstrating that both the NKG2A and CD3 arms contribute to the ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...